Skip to content

AngioDynamics ANGO Price / sales

Price / sales at other companies

Abbott logo
AbbottABT
-1.5×
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
2.1×-1.2×
TFX
TeleflexTFX
2.5×-1.1×
Stryker logo
StrykerSYK
-1.1×
Merit Medical Systems logo
Merit Medical SystemsMMSI
2.7×-1.8×
ICU Medical logo
ICU MedicalICUI
1.5×+0.1×

Other financials

Income statement

See full
Revenue$78.4M+8.9%
Gross profit$41.5M+6.7%
Operating income-$13.0M-29.8%
Net income-$8.1M-83.4%
EPS (diluted)-$0.19-72.7%

Balance sheet

See full
Cash & equivalents$37.8M-15.5%
Total debt$7.9M+10.2%
Total equity$173.4M-6.7%
Total assets$260.7M-8.7%

Cash flow

See full
Operating cash flow-$3.1M+76.4%
CapEx$1.0M-43.5%
Free cash flow-$4.1M+72.4%

Valuation

See full
Market cap$564.42M+38.7%
Enterprise value$534.51M+48.0%

Profitability

See full
Gross margin54.3%-0.1pp
Operating margin-11.3%-2.9pp
Net margin-10%-2.4pp
FCF margin5.5%

Returns & leverage

See full
Return on equity-17.5%-2.2pp
Debt / equity0.0×
Current ratio2.4×+0.1×

Where this comes from

Calculated from AngioDynamics’s reported figures.

Based on the most recent quarter.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AngioDynamics's price / sales?
AngioDynamics (ANGO) reported price / sales of 1.5× in Q4 2025.
How has AngioDynamics's price / sales changed year-over-year?
AngioDynamics's price / sales increased by 13.3% year-over-year, from 1.3× to 1.5×.
What is the long-term trend for AngioDynamics's price / sales?
Over 4 years (2021 to 2025), AngioDynamics's price / sales has grown at a -18.6% compound annual growth rate (CAGR), from 3.1× to 1.3×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.